The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors

被引：75

作者：

Tormo, Eduardo ^{[1
,2
]}

Ballester, Sandra ^{[1
]}

Adam-Artigues, Anna ^{[1
]}

Burgues, Octavio ^{[1
,2
,3
]}

Alonso, Elisa ^{[1
,2
,3
]}

Bermejo, Begona ^{[1
,2
]}

Menendez, Silvia ^{[4
]}

Zazo, Sandra ^{[5
]}

Madoz-Gurpide, Juan ^{[5
]}

Rovira, Ana ^{[4
,6
]}

Albanell, Joan ^{[4
,6
,7
]}

Rojo, Federico ^{[5
]}

Lluch, Ana ^{[1
,2
,8
]}

Eroles, Pilar ^{[1
,2
,9
]}

机构：

[1] INCLIVA Biomed Res Inst, Valencia, Spain

[2] Hosp Clin Univ CIBERONC, Oncol & Hematol Dept, Valencia, Spain

[3] Hosp Clin Univ, Pathol Dept, Valencia, Spain

[4] IMIM Hosp Mar Res Inst, Canc Res Program, Barcelona, Spain

[5] IIS Fdn Jimenez Diaz CIBERONC, Pathol Dept, Madrid, Spain

[6] Hosp Mar CIBERONC, Med Oncol Dept, Barcelona, Spain

[7] Univ Pompeu Fabra, Barcelona, Spain

[8] Univ Valencia, Valencia, Spain

[9] COST Act CA15204, Brussels, Belgium

来源：

SCIENTIFIC REPORTS | 2019年 / 9卷 / 1期

关键词：

DNA-DAMAGE RESPONSE; MIR-449A; TARGET; E2F1; PROLIFERATION; CYTOTOXICITY; INVOLVEMENT; ACTIVATION; THERAPY; LOOP;

D O I：

10.1038/s41598-019-41472-y

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The mechanisms of chemotherapy resistance in triple negative breast cancer remain unclear, and so, new molecules which might mediate this resistance could optimize treatment response. Here we analyzed the involvement of the miRNA-449 family in the response to doxorubicin. The cell viability, cell-cycle phases, and the expression of in silico target genes and proteins of sensitive/resistant triple negative breast cancer cell lines were evaluated in response to doxorubicin treatment and after gain/loss of miRNAs-449 function achieved by transient transfection. Triple negative breast cancer patients were selected for ex vivo experiments and to evaluate gene and miRNAs expression changes after treatment, as well as survival analysis by Kaplan-Meier. Doxorubicin treatment upregulated miRNAs-449 and DNA-damage responder factors E2F1 and E2F3 in triple negative breast cancer sensitive breast cancer cells, while expression remained unaltered in resistant ones. In vitro overexpression of miRNAs-449 sensitized cells to the treatment and significantly reduced the resistance to doxorubicin. These changes showed also a strong effect on cell cycle regulation. Finally, elevated levels of miRNA-449a associated significantly with better survival in chemotherapy-treated triple negative breast cancer patients. These results reveal for the first time the involvement of the miRNA-449 family in doxorubicin resistance and their predictive and prognostic value in triple negative breast cancer patients.

引用

页数：14

共 40 条

[11] Mechanisms of translational control by the 3′ UTR in development and differentiation [J].

de Moor, CH ;

Meijer, H ;

Lissenden, S .

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2005, 16 (01) :49-58

[12] E2F1 is crucial for E2F-dependent apoptosis [J].

Denchi, EL ;

Helin, K .

EMBO REPORTS, 2005, 6 (07) :661-667

[13] Triple-negative breast cancer: Clinical features and patterns of recurrence [J].

Dent, Rebecca ;

Trudeau, Maureen ;

Pritchard, Kathleen I. ;

Hanna, Wedad M. ;

Kahn, Harriet K. ;

Sawka, Carol A. ;

Lickley, Lavina A. ;

Rawlinson, Ellen ;

Sun, Ping ;

Narod, Steven A. .

CLINICAL CANCER RESEARCH, 2007, 13 (15) :4429-4434

[14] Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1 [J].

Harbour, JW ;

Luo, RX ;

Santi, AD ;

Postigo, AA ;

Dean, DC .

CELL, 1999, 98 (06) :859-869

[15] Treatment-related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer [J].

Hardenbergh, PH ;

Recht, A ;

Gollamudi, S ;

Come, SE ;

Hayes, DF ;

Shulman, LN ;

O'Neill, A ;

Gelman, RS ;

Silver, B ;

Harris, JR .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (01) :69-72

[16] miR-449a Regulates Proliferation and Chemosensitivity to Cisplatin by Targeting Cyclin D1 and BCL2 in SGC7901 Cells [J].

Hu, Jianghong ;

Fang, Yue ;

Cao, Yuan ;

Qin, Rong ;

Chen, Qiaoyun .

DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (02) :336-345

[17] Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer [J].

Jeon, Hyo Sung ;

Lee, Soo Young ;

Lee, Eun Jin ;

Yun, Seong Cheol ;

Cha, Eun Jung ;

Choi, Eugene ;

Na, Moon Jun ;

Park, Jae Yong ;

Kang, Jaeku ;

Son, Ji Woong .

LUNG CANCER, 2012, 76 (02) :171-176

[18] Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres [J].

Ji, Qing ;

Hao, Xinbao ;

Meng, Yang ;

Zhang, Min ;

DeSano, Jeffrey ;

Fan, Daiming ;

Xu, Liang .

BMC CANCER, 2008, 8 (1)

[19] Adjuvant treatments for triple-negative breast cancers [J].

Joensuu, H. ;

Gligorov, J. .

ANNALS OF ONCOLOGY, 2012, 23 :40-45

[20] miR-449 inhibits cell proliferation and is down-regulated in gastric cancer [J].

Kheir, Tony Bou ;

Futoma-Kazmierczak, Ewa ;

Jacobsen, Anders ;

Krogh, Anders ;

Bardram, Linda ;

Hother, Christoffer ;

Gronbaek, Kirsten ;

Federspiel, Birgitte ;

Lund, Anders H. ;

Friis-Hansen, Lennart .

MOLECULAR CANCER, 2011, 10

← 1 2 3 4 →